Zdrowie i gospodarka · 03/05/2012

FDA Hosts Public Workshop to Discuss Risk Evaluation and Mitigation Strategy Assessments

The FDA is hosting a public workshop to gather input on survey methodologies and instruments to evaluate patients' and healthcare providers' knowledge about the risks of drugs marketed with an approved Risk Evaluation and Mitigation Strategy (REMS). The workshop aims to initiate constructive dialogue among regulators, researchers, and industry stakeholders.